Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ZBTB7C | hg38_v1_chr18_-_48137295_48137361 | 0.52 | 2.4e-03 | Click! |
ZBTB7A | hg38_v1_chr19_-_4065732_4065911 | -0.16 | 3.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_-_132777229 Show fit | 6.58 |
ENST00000378721.8
ENST00000378719.7 ENST00000378701.5 |
septin 8 |
|
chr5_-_132777344 Show fit | 6.16 |
ENST00000378706.5
|
septin 8 |
|
chr5_-_132777371 Show fit | 5.95 |
ENST00000620483.4
|
septin 8 |
|
chr5_-_132777215 Show fit | 5.68 |
ENST00000458488.2
|
septin 8 |
|
chr5_-_132777404 Show fit | 5.54 |
ENST00000296873.11
|
septin 8 |
|
chr11_-_12009358 Show fit | 5.23 |
ENST00000326932.8
|
dickkopf WNT signaling pathway inhibitor 3 |
|
chr12_+_57550027 Show fit | 4.88 |
ENST00000674619.1
ENST00000676359.1 ENST00000286452.5 ENST00000455537.7 ENST00000676457.1 |
kinesin family member 5A |
|
chr5_-_132777866 Show fit | 4.82 |
ENST00000448933.5
|
septin 8 |
|
chr11_-_12009199 Show fit | 4.29 |
ENST00000533813.5
|
dickkopf WNT signaling pathway inhibitor 3 |
|
chr4_+_41256921 Show fit | 3.86 |
ENST00000284440.9
ENST00000508768.5 ENST00000512788.1 |
ubiquitin C-terminal hydrolase L1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 11.8 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
0.9 | 7.5 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
1.7 | 6.9 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.1 | 5.3 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
1.2 | 4.9 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.0 | 4.9 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 4.9 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
1.5 | 4.6 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.6 | 4.5 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.1 | 4.3 | GO:0060325 | face morphogenesis(GO:0060325) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 9.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 8.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 5.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 4.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 4.6 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.6 | 4.5 | GO:0097513 | myosin II filament(GO:0097513) |
0.0 | 3.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 3.4 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 3.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 2.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 6.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 5.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 5.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 5.0 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 4.9 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 4.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.3 | 4.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.6 | 3.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 3.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 3.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 11.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 7.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 2.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 1.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 1.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 1.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 1.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 1.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 1.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 1.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 6.7 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 5.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 4.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 4.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 4.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 4.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 2.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 2.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 2.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |